Biocon Biologics said it has signed a settlement and licence pact with drug firm Janssen to market its biosimilar item to deal with different sicknesses like psoriasis, Crohn's illness and ulcerative colitis, in the US. The organization's item...
Stryker, a global leader in medical technologies, officially expanded its prototype and testing facility in India today, marking significant growth of its RandD footprint.
Veradigm, Inc., a leading provider of healthcare data and technology products and solutions, announced that it has signed a definitive agreement to acquire ScienceIO, a leading AI platform and foundation model provider for healthcare.
Viatris Inc., a global healthcare company, and Idorsia Ltd announced they have entered into agreements for a significant worldwide research and development collaboration under which Viatris will receive exclusive worldwide development
Bridgewater's Amneal Pharmaceuticals, a global pharmaceutical company, announced that it has signed an exclusive license agreement for IPX203 in the European Union, United Kingdom and Switzerland with Italy's Zambon Biotech SA, part of the Zambon
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral gene therapies with minimally-invasive delivery technology, launches with seed finance from Pureos Bioventures and ND Capital.
Virtual Incision, a company in the cultivate (MD) portfolio, has received marketing authorization from the US FDA for the MIRA Surgical System (MIRA).
Commissioner Abhimanyu Kale of the Maharashtra Food and Drug Administration (FDA) led a raid on Mumbai-based Raj Products' premises to tackle illicit activities in the cosmetics industry.
AbbVie Inc. and OSE Immunotherapeutics SA, a clinical-stage immunotherapy company, announced a strategic partnership to develop OSE-230, a monoclonal antibody designed to resolve chronic and severe inflammation, currently in pre-clinical development.
Roche Pharma India reported the launch of its blockbuster advancement drug, Ocrevus (ocrelizumab), for the treatment of multiple sclerosis (MS), growing its nervous system science portfolio to take special care of neglected needs of various...
, CDSCO.jpg)
